Akron’s Recombinant Human Granulocyte-Colony Stimulating Factor (rHu G-CSF) Solution product is manufactured following all relevant cGMP guidelines for ancillary materials. Akron’s rHu G-CSF is a single chain, approximately 18 kDa, non-glycosylated cytokine analog expressed in E. coli. It is purified in a pharmaceutical facility without the use of histidine tags and nickel columns. Sterile filtration with aseptic filling and lyophilization are performed in-house with Endotoxin and Sterility testing performed per USP/EP on the final product; the liquid product is packaged in sterile vials and available in 300 μg aliquots at a concentration of 300 μg/mL.
For research use or further manufacturing use in ex vivo cell therapy applications. This product is not intended for direct in vivo use or for direct clinical use as a drug, therapeutic, biologic, or medical device.
• Appearance
• pH
• Protein Concentration (HPLC)
• Biological Activity
• Molecular Weight
• Western Blot
• Purity (Non-Reducing SDS-PAGE)
• Purity (Reducing SDS-PAGE)
• Host Cell Derived Proteins
• Host Cell DNA
• Bacterial Endotoxins
• Sterility
In vivo, G-CSF stimulates the production of granulocytes and hematopoietic stem cells (HSCs) from bone marrow and stimulates the proliferation, differentiation, and activation of neutrophils. Akron’s cGMP compliant rHu G-CSF can be used to promote the ex vivo expansion of neutrophils and HSCs.
Liquid Vials (300 μg) Cat # AK8248-0300
Protein Concentration (300 μg/mL)